NFG
TEVA icon

Nations Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Nations Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,777
Closed -$358K – 163
2017
Q2 		$358K Buy
+10,777
New +$334K 0.29% 101

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Nations Financial Group's TEVA Position: Q3 2017 in Review

Nations Financial Group sold out of Teva Pharmaceuticals (TEVA) in Q3 2017, closing a stake of 10,777 shares — an estimated $358K sold.

Nations Financial Group first reported a position in TEVA in Q2 2017 and held it in 1 quarter. The position peaked at $358K in Q2 2017. 535 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Nations Financial Group reported no remaining Teva Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Nations Financial Group sold 10,777 Teva Pharmaceuticals shares in Q3 2017, an estimated $358K.
  • Nations Financial Group first reported a position in Teva Pharmaceuticals in Q2 2017 and held it in 1 quarter.
  • Nations Financial Group's Teva Pharmaceuticals position peaked at $358K in Q2 2017.
  • 535 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2017.

Based on Nations Financial Group's 13F filing for Q3 2017, filed 13 Nov 2017.